Publications
Publications
Show Results For
- All HBS Web
(445)
- Faculty Publications (70)
←
Page 4 of 70
Results
- 30 Jul 2010
- Other Presentation
Creating a Value-Based Health Care Organization: The Strategic Agenda
This presentation draws on Redefining Health Care: Creating Value-Based Competition on Results (with Elizabeth O. Teisberg), Harvard Business School Press, May 2006; "A Strategy for Health Care Reform—Toward a Value-Based System," New England Journal of... View Details
- 15 Jul 2010
- Other Presentation
Value-Based Health Care Delivery
This presentation draws on Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006, and Porter, Michael E. "A Strategy for Health Care Reform," New England... View Details
- 17 Jun 2010
- Other Presentation
Value-Based Health Care Delivery
This presentation draws on Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006, and Porter, Michael E. "A Strategy for Health Care Reform." New England Journal of... View Details
- 8 Jun 2010
- Other Presentation
Value-Based Health Care Delivery
This presentation draws on Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006, and Porter, Michael E. "A Strategy for Health Care Reform," New England... View Details
- 4 Jun 2010
- Other Presentation
Value-Based Health Care Delivery
This presentation draws on Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006, and Porter, Michael E. "A Strategy for Health Care Reform," New England... View Details
- November 2009 (Revised December 2009)
- Case
GTC Biotherapeutics: Developing Medicines in the Milk of Goats
By: Ray A. Goldberg and Sarah Morton
GTC is the first company in the animal world to receive FDA approval of a transgenic pharmaceutical. What are the implications for other firms in plants and animals and their opportunities to produce new medicines in an economical and safe fashion? View Details
- November 2009 (Revised March 2010)
- Case
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon
In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details
- October 2009 (Revised August 2014)
- Case
Tengion: Bringing Regenerative Medicine to Life
By: Elie Ofek and Polly Ross Ribatt
Tengion is a young biotech company that is at the frontier of regenerative medicine—a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late... View Details
- July 2002 (Revised August 2002)
- Case
Washington Hospital Center (A): Rescuing Emergency Medicine
By: Rosabeth M. Kanter and Michelle Heskett
Dr. Craig Feied and Dr. Mark Smith, recruited to turn around the Washington Hospital Center Emergency Department, prepare to roll out their most revolutionary change yet--an information system that could radically improve the practice of emergency medicine. A review of... View Details
- March 1999 (Revised February 2000)
- Case
Ken Hakuta: AllHerb.com
By: Teresa M. Amabile and Nicole Tempest
Ken Hakuta had been an entrepreneur all his life. Having started a number of consumer-oriented ventures, he became well-known as "Dr. Fad," the initiator of the "Wacky Wallwalker" toy craze in the 1980s. Wishing to strike out in an exciting new direction in 1998, he... View Details